Ann: Kazia releases final data from P2 paxalisib trial, page-67

Dude I've always liked your posts. I get it was dissappointing to not get the full data on what seemed like the only sure thing ann.
The truth is as JG says no value now without a deal.
Hanging on for data is pointless now and those other trials are really not held to account. Look at BCBM a year late and not a word from the bonus boy.

If you like the cause maybe spread your risk as I, Needle and Spyglass and maybe some others its reassuring. I mean CHM is lower now too so its same same just with a better risk profile.

You are still sitting on a good profit.
I think there may be a deal probably dissappointing but hopefully get $2.0.

Good luck.